Doxycycline Hyclate is a tetracycline antibiotic indicated for respiratory and sexually transmitted infections, acne and malaria prophylaxis. We supply it to US manufacturers of tablets, capsules and delayed-release tablets.
Data from PubChem (CID 54686183) and FDA’s substance registry
CAS number
24390-14-5
Molecular formula
C46H58Cl2N4O18
Molecular weight
1025.9g/mol
FDA UNII
IUPAC name
bis((4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide);ethanol;hydrate;dihydrochloride
InChIKey
UHHHTIKWXBRCLT-VDBOFHIQSA-N
- Appearance
- Yellow to light yellow crystalline powder.
- Solubility
- Soluble in water.
Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.
Worth settling with your inquiry
Sensitive to light. The epimers 4-epidoxycycline and 6-epidoxycycline, and metacycline, are the impurities to compare between sources. Doxycycline monohydrate is a separate API.
On the US market
- Reference product
- VibramycinNDA 050007
- Approved ANDAs
- 50 with a marketed product
- Approved forms and strengths
- Tablet 20 mg, 50 mg, 75 mg, 100 mg, 150 mg
- Injection 100 mg per vial, 200 mg per vial
- Capsule 50 mg, 100 mg
- Delayed-release tablet 50 mg, 60 mg, 75 mg, 100 mg, 150 mg, 200 mg
Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. Strengths of salt forms are stated as the active moiety. The brand name belongs to its owner and identifies the reference product only.
Grade
USP or Ph. Eur. where a monograph exists, or your own specification.
Quantities
From development quantities for formulation work to commercial supply.
Packaging
To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.
Regulatory filings
US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.
Documents available with a quote
- Specification and certificate of analysis
- Safety data sheet
- Method of analysis
- DMF letter of authorization, where a US DMF is filed
- GMP certificate and inspection history of the site
- Residual solvents and elemental impurities statements
- Nitrosamine risk assessment
- TSE/BSE statement
Need something else for your QA file? Email info@yogpharma.com